| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/29/2000 | US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination |
| 08/29/2000 | US6110725 Lactobacillus strains which survive in the intestine, adhere to human intestinal cells, and increase phagocytosis of macrophages; for preparation of food products |
| 08/29/2000 | US6110723 Yfii pseudouridine synthase |
| 08/29/2000 | US6110722 Amino acid sequence of subunit of mitochondrial adenosine triphosphatase complex; diagnosis, prevention, and treatment of cancer, muscular disorders, immune disorders/autoimmune disorders, and nervous system disorders; anticancer agents |
| 08/29/2000 | US6110721 Isolated polypeptide at least about 80% homologous to and possesses at least one immune epitope of thrombin reference amino acid sequence; anticoagulants and procoagulants; diagnosis of blood disorders; drug screening; antitumor agents |
| 08/29/2000 | US6110720 Orpinomyces cellulase CelE protein and coding sequences |
| 08/29/2000 | US6110719 Phytase |
| 08/29/2000 | US6110711 Method of defining cell types by probing comprehensive expression libraries with amplified RNA |
| 08/29/2000 | US6110710 Sequence modification of oligonucleotide primers to manipulate non-templated nucleotide addition |
| 08/29/2000 | US6110706 Amino acid sequences; for increased immunogenicity |
| 08/29/2000 | US6110705 Recombinant Chlamydia trachomatis pgp3 fusion protein |
| 08/29/2000 | US6110703 Production in yeast by culturing strain having reduced yap3 protease activity and transformed with hybrid vector encoding heterologous polypeptide up to 55 amino acids and having 0 to 3 disulfide bonds; yield is 2-fold higher |
| 08/29/2000 | US6110702 Nucleotide sequences of which regulate prostate specific antigen; gene therapy; anticarcinogenic agents; recombinant production of proteins |
| 08/29/2000 | US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
| 08/29/2000 | US6110700 Nucleic acids that code a modulator of kinase activity; for the diagnosis tumorous condition; for development of models for the evaluation cancer in organ and tissues |
| 08/29/2000 | US6110695 Detecting modulators of chemotaxis between lymphocyte attractant and burkitt's lymphoma receptor polypeptide; incubating a cell with attractant and modulator, detecting binding, calcium mobility or chemotaxis, compare to reference |
| 08/29/2000 | US6110694 Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules |
| 08/29/2000 | US6110693 Methods of assaying receptor activity and constructs useful in such methods |
| 08/29/2000 | US6110691 Polypeptide associated with apoptosis; for the detection of modulators of apoptosis |
| 08/29/2000 | US6110686 DNA hybridizing to a human cystatin-like protein (CSTIN) |
| 08/29/2000 | US6110685 Polynucleotide sequence coding translational activation polypeptide; for prevention of infecttion; bactericides; microbicides |
| 08/29/2000 | US6110684 Screening for fitting defects in nucleotide sequences; incubation of nucleic acid with a resolvase, screening for resolvase binding, binding is an indication of nucleic acid fitting defect |
| 08/29/2000 | US6110681 Primers and probes for the amplification, detection and typing of Mycoplasma pneumoniae |
| 08/29/2000 | US6110680 Detection and classification of ribonucleic acid sequences; preparing complementary nucleotide sequences, insertion into vector, transform cells, generate nucleic acid sequences, generate transcripts, divide, amplify and resolve transcripts |
| 08/29/2000 | US6110678 Two-step hybridization and capture of a polynucleotide |
| 08/29/2000 | US6110675 Reagents and methods useful for detecting diseases of the prostate |
| 08/29/2000 | US6110674 Apparatus and method for nucleic acid isolation using supercritical fluids |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | US6110668 Gene synthesis method |
| 08/29/2000 | US6110667 Processes, apparatus and compositions for characterizing nucleotide sequences based on K-tuple analysis |
| 08/29/2000 | US6110666 Detection of regulatory sequences; transforming a cell with a genetically engineered expression vector, monitor preferential gene expression in cell |
| 08/29/2000 | US6110664 Antisense inhibition of G-alpha-S1 expression |
| 08/29/2000 | US6110661 Bioluminescent reporter bacterium |
| 08/29/2000 | US6110507 Human 3-hydroxyisobutryl-coenzyme a hydrolase |
| 08/29/2000 | US6110490 Comprising a multilayer membrane surrounding an internal aqueous liposome comprising atleast one cationic lipopolyamine and one neutral lipid |
| 08/29/2000 | US6110470 Dna molecules with encoded polypeptides with amino acid sequences |
| 08/29/2000 | US6110469 Hybrid plasmid for 38 kDa antigen of M. tuberculosis |
| 08/29/2000 | US6110467 Isolated porcine respiratory and reproductive virus, vaccines and methods of protecting a pig against a disease caused by a porcine respiratory and reproductive virus |
| 08/29/2000 | US6110466 Modified plant viruses as vectors |
| 08/29/2000 | US6110464 Polypeptides with amino acid sequences |
| 08/29/2000 | US6110462 Enzymatic DNA molecules that contain modified nucleotides |
| 08/29/2000 | US6110461 Reovirus for the treatment of neoplasia |
| 08/29/2000 | US6110460 Methods of using morphogen analogs |
| 08/29/2000 | US6110458 Cancer therapy utilizing ex vivo gene transduction |
| 08/29/2000 | US6110456 Oral delivery or adeno-associated viral vectors |
| 08/29/2000 | US6110428 Device for use in the isolation of a biological material such as nucleic acid |
| 08/29/2000 | US6110426 Methods for fabricating microarrays of biological samples |
| 08/29/2000 | US6110363 From very small quantities of various starting materials without being contaminated by genomic dna; requires small number of apparatuses and allow to isolate the two nucleic acid fractions very quickly |
| 08/29/2000 | CA2034487C Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
| 08/29/2000 | CA2015687C Human serum albomin fusion polypeptide |
| 08/29/2000 | CA2010275C Pancreatic islet cell antigens obtained by molecular cloning |
| 08/29/2000 | CA1341090C Vampire bat plasminogen activators |
| 08/26/2000 | CA2296792A1 Expressed sequence tags and encoded human proteins |
| 08/26/2000 | CA2263067A1 Method of modifying plant morphology, biochemistry and physiology |
| 08/25/2000 | CA2300692A1 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 08/24/2000 | WO2000049557A2 Computer-implemented nucleic acid isolation method and apparatus |
| 08/24/2000 | WO2000049416A2 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 08/24/2000 | WO2000049180A1 Detection of nucleic acid hybrids |
| 08/24/2000 | WO2000049179A1 Methods for determining the presence of nucleic acid target sequences and applications thereof |
| 08/24/2000 | WO2000049178A2 Polynucleotide sequencing method |
| 08/24/2000 | WO2000049176A1 Method and apparatus for nucleic acid strand separation |
| 08/24/2000 | WO2000049173A2 Method and sample support system for separating and processing substances in situ |
| 08/24/2000 | WO2000049168A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
| 08/24/2000 | WO2000049167A1 Latency-associated regulatory region from herpesvirus saimiri (hvs) |
| 08/24/2000 | WO2000049166A2 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 08/24/2000 | WO2000049165A1 Methods for modulating the levels of organic sulfur compounds in plants |
| 08/24/2000 | WO2000049164A1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 08/24/2000 | WO2000049163A1 Production of heterologous polypeptides from freshwater caulobacter |
| 08/24/2000 | WO2000049162A2 Compositions and methods for non-targeted activation of endogenous genes |
| 08/24/2000 | WO2000049161A1 REPORTER CONSTRUCTS TO MONITOR cAMP LEVELS |
| 08/24/2000 | WO2000049160A1 Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders |
| 08/24/2000 | WO2000049159A1 Collagen-binding physiologically active polypeptide |
| 08/24/2000 | WO2000049158A2 Psa and klk-2 splicing variants |
| 08/24/2000 | WO2000049157A2 Compositions and methods for altering sulfur content in plants |
| 08/24/2000 | WO2000049156A2 Lysophosphatidic acid acetyltransferases |
| 08/24/2000 | WO2000049155A1 Genes encoding proteins having activity of transferring sugar onto aurone |
| 08/24/2000 | WO2000049154A1 Splice variant of p101 protein |
| 08/24/2000 | WO2000049153A1 Fucosyl transferase gene |
| 08/24/2000 | WO2000049152A1 Nucleic acids that code for a nucleobase transporter |
| 08/24/2000 | WO2000049151A2 POLYMORPHIC HUMAN GABAA RECEPTOR α-6 SUBUNIT |
| 08/24/2000 | WO2000049150A1 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 08/24/2000 | WO2000049149A1 Novel tnf receptor-like proteins |
| 08/24/2000 | WO2000049148A1 Novel cytokine recfptor-like protein |
| 08/24/2000 | WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | WO2000049146A1 Malaria vaccine |
| 08/24/2000 | WO2000049145A2 Hematopoietic genes hzf and hhl and polypeptides encoded thereof |
| 08/24/2000 | WO2000049144A2 Pyk2 binding proteins |
| 08/24/2000 | WO2000049143A1 Method for analyzing gene expression frequency |
| 08/24/2000 | WO2000049142A1 Method for producing polymers |
| 08/24/2000 | WO2000049138A2 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of stomatic cells |
| 08/24/2000 | WO2000049137A2 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 08/24/2000 | WO2000049133A1 Method for producing l-sorbose |
| 08/24/2000 | WO2000049132A2 Uses of transgenic animals containing a type x collagen mutant |
| 08/24/2000 | WO2000049046A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/24/2000 | WO2000049043A2 Human lipid-associated proteins |
| 08/24/2000 | WO2000049039A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 08/24/2000 | WO2000049035A1 Gene silencing |
| 08/24/2000 | WO2000049031A2 Method for isolating nucleic acids |
| 08/24/2000 | WO2000048991A1 Salicylamide-lanthanide complexes for use as luminescent markers |